AAAAAA

   
Results: 1-10 |
Results: 10
Determination of exogenous melatonin and its 6-hydroxy metabolite in humanplasma by liquid chromatography-mass spectrometry
Authors: Hartter, S Morita, S Bodin, K Ursing, C Tybring, G Bertilsson, L
Citation: S. Hartter et al., Determination of exogenous melatonin and its 6-hydroxy metabolite in humanplasma by liquid chromatography-mass spectrometry, THER DRUG M, 23(3), 2001, pp. 282-286
Role of CYP2C9 polymorphism in losartan oxidation
Authors: Yasar, U Tybring, G Hidestrand, M Oscarson, M Ingelman-Sundberg, M Dahl, ML Eliasson, E
Citation: U. Yasar et al., Role of CYP2C9 polymorphism in losartan oxidation, DRUG META D, 29(7), 2001, pp. 1051-1056
Different enantioselective 9-hydroxylation of risperidone by the two humanCYP2D6 and CYP3A4 enzymes
Authors: Yasui-Furukori, N Hidestrand, M Spina, E Facciola, G Scordo, MG Tybring, G
Citation: N. Yasui-furukori et al., Different enantioselective 9-hydroxylation of risperidone by the two humanCYP2D6 and CYP3A4 enzymes, DRUG META D, 29(10), 2001, pp. 1263-1268
Cytochrome P-450 isoforms involved in melatonin metabolism in human liver microsomes
Authors: Facciola, G Hidestrand, M von Bahr, C Tybring, G
Citation: G. Facciola et al., Cytochrome P-450 isoforms involved in melatonin metabolism in human liver microsomes, EUR J CL PH, 56(12), 2001, pp. 881-888
Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test
Authors: Laine, K Tybring, G Hartter, S Andersson, K Svensson, JO Widen, J Bertilsson, L
Citation: K. Laine et al., Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test, CLIN PHARM, 70(4), 2001, pp. 327-335
Orally given melatonin may serve as a probe drug for cytochrome P450 1A2 activity in vivo: A pilot study
Authors: Hartter, S Ursing, C Morita, S Tybring, G von Bahr, C Christensen, M Rojdmark, S Bertilsson, L
Citation: S. Hartter et al., Orally given melatonin may serve as a probe drug for cytochrome P450 1A2 activity in vivo: A pilot study, CLIN PHARM, 70(1), 2001, pp. 10-16
Fluvoxamine but not citalopram increases serum melatonin in healthy subjects - an indication that cytochrome P-450 CYP1A2 and CYP2C19 hydroxylate melatonin
Authors: von Bahr, C Ursing, C Yasui, N Tybring, G Bertilsson, L Rojdmark, S
Citation: C. Von Bahr et al., Fluvoxamine but not citalopram increases serum melatonin in healthy subjects - an indication that cytochrome P-450 CYP1A2 and CYP2C19 hydroxylate melatonin, EUR J CL PH, 56(2), 2000, pp. 123-127
Effects of omeprazole on intragastric pH and plasma gastrin are dependent on the CYP2C19 polymorphism
Authors: Sagar, M Tybring, G Dahl, ML Bertilsson, L Seensalu, R
Citation: M. Sagar et al., Effects of omeprazole on intragastric pH and plasma gastrin are dependent on the CYP2C19 polymorphism, GASTROENTY, 119(3), 2000, pp. 670-676
No sex-related differences but significant inhibition by oral contraceptives of CYP2C19 activity as measured by the probe drugs mephenytoin and omeprazole in healthy Swedish white subjects
Authors: Laine, K Tybring, G Bertilsson, L
Citation: K. Laine et al., No sex-related differences but significant inhibition by oral contraceptives of CYP2C19 activity as measured by the probe drugs mephenytoin and omeprazole in healthy Swedish white subjects, CLIN PHARM, 68(2), 2000, pp. 151-159
Stereospecific analysis of omeprazole supports artemisinin as a potent inducer of CYP2C19
Authors: Mihara, K Svensson, USH Tybring, G Hai, TN Bertilsson, L Ashton, M
Citation: K. Mihara et al., Stereospecific analysis of omeprazole supports artemisinin as a potent inducer of CYP2C19, FUN CL PHAR, 13(6), 1999, pp. 671-675
Risultati: 1-10 |